LB PHARMACEUTICALS INC - 8-K Filing
LB Pharmaceuticals appoints Joseph Miller as CFO effective September 2, 2026 (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $LBRX